Base to Base biotech podcast 26: Stand Up To Cancer Day

This week, we have three interviews to mark Stand Up To Cancer Day. We have conversations with Simon Kerry, co-founder and CEO of Curve Therapeutics; Poolbeg Pharma CEO Jeremy Skillington; and Stefano Gulla, CSO of Kling Biotherapeutics.

Interview times:

03:12 Curve Therapeutics

21:32 Kling Bio

37:10 Poolbeg Pharma

Microcycles to address cancer

Curve Therapeutics, a private biotechnology company using its gene-encoded Microcycle discovery platform to build a pipeline of innovative cyclic peptide and small molecule drugs to address high priority intracellular disease targets, with an initial focus on cancer, immunology, and inflammation.